0.009544 0.005510 0.000000 0.000000 0.011020 0.000000 0.000000 0.000000 0.003974 0.00000 0.00000 0.00000 Brown, N.R. Petri, E. Lowe, E.D. Skamnaki, V. Johnson, L.N. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 12 90.00 90.00 120.00 104.780 104.780 251.635 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C4 H10 N O6 P 199.099 n PHOSPHOTHREONINE PHOSPHONOTHREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking N 1 N N N 2 S C N 3 N C N 4 N O N 5 N C N 6 N O N 7 N H N 8 N H N 9 N H N 10 N H N 11 N H N 12 N H N 13 N H N 14 N N N 15 S C N 16 N C N 17 N O N 18 N C N 19 N C N 20 N C N 21 N N N 22 N C N 23 N N N 24 N N N 25 N O N 26 N H N 27 N H N 28 N H N 29 N H N 30 N H N 31 N H N 32 N H N 33 N H N 34 N H N 35 N H N 36 N H N 37 N H N 38 N H N 39 N H N 40 N H N 41 N N N 42 S C N 43 N C N 44 N O N 45 N C N 46 N C N 47 N O N 48 N N N 49 N O N 50 N H N 51 N H N 52 N H N 53 N H N 54 N H N 55 N H N 56 N H N 57 N H N 58 N N N 59 S C N 60 N C N 61 N O N 62 N C N 63 N C N 64 N O N 65 N O N 66 N O N 67 N H N 68 N H N 69 N H N 70 N H N 71 N H N 72 N H N 73 N H N 74 N N N 75 R C N 76 N C N 77 N O N 78 N C N 79 N S N 80 N O N 81 N H N 82 N H N 83 N H N 84 N H N 85 N H N 86 N H N 87 N H N 88 N N N 89 S C N 90 N C N 91 N O N 92 N C N 93 N C N 94 N C N 95 N O N 96 N N N 97 N O N 98 N H N 99 N H N 100 N H N 101 N H N 102 N H N 103 N H N 104 N H N 105 N H N 106 N H N 107 N H N 108 N N N 109 S C N 110 N C N 111 N O N 112 N C N 113 N C N 114 N C N 115 N O N 116 N O N 117 N O N 118 N H N 119 N H N 120 N H N 121 N H N 122 N H N 123 N H N 124 N H N 125 N H N 126 N H N 127 N N N 128 N C N 129 N C N 130 N O N 131 N O N 132 N H N 133 N H N 134 N H N 135 N H N 136 N H N 137 N N N 138 S C N 139 N C N 140 N O N 141 N C Y 142 N C Y 143 N N Y 144 N C Y 145 N C Y 146 N N N 147 N O N 148 N H N 149 N H N 150 N H N 151 N H N 152 N H N 153 N H N 154 N H N 155 N H N 156 N H N 157 N H N 158 N O N 159 N H N 160 N H N 161 N N N 162 S C N 163 N C N 164 N O N 165 S C N 166 N C N 167 N C N 168 N C N 169 N O N 170 N H N 171 N H N 172 N H N 173 N H N 174 N H N 175 N H N 176 N H N 177 N H N 178 N H N 179 N H N 180 N H N 181 N H N 182 N H N 183 N N N 184 S C N 185 N C N 186 N O N 187 N C N 188 N C N 189 N C N 190 N C N 191 N O N 192 N H N 193 N H N 194 N H N 195 N H N 196 N H N 197 N H N 198 N H N 199 N H N 200 N H N 201 N H N 202 N H N 203 N H N 204 N H N 205 N N N 206 S C N 207 N C N 208 N O N 209 N C N 210 N C N 211 N C N 212 N C N 213 N N N 214 N O N 215 N H N 216 N H N 217 N H N 218 N H N 219 N H N 220 N H N 221 N H N 222 N H N 223 N H N 224 N H N 225 N H N 226 N H N 227 N H N 228 N H N 229 N H N 230 N N N 231 S C N 232 N C N 233 N O N 234 N C N 235 N C N 236 N S N 237 N C N 238 N O N 239 N H N 240 N H N 241 N H N 242 N H N 243 N H N 244 N H N 245 N H N 246 N H N 247 N H N 248 N H N 249 N H N 250 N N N 251 S C N 252 N C N 253 N O N 254 N C Y 255 N C Y 256 N C Y 257 N C Y 258 N C Y 259 N C Y 260 N C N 261 N O N 262 N H N 263 N H N 264 N H N 265 N H N 266 N H N 267 N H N 268 N H N 269 N H N 270 N H N 271 N H N 272 N H N 273 N N N 274 S C N 275 N C N 276 N O N 277 N C N 278 N C N 279 N C N 280 N O N 281 N H N 282 N H N 283 N H N 284 N H N 285 N H N 286 N H N 287 N H N 288 N H N 289 N H N 290 N N N 291 S C N 292 N C N 293 N O N 294 N C N 295 N O N 296 N O N 297 N H N 298 N H N 299 N H N 300 N H N 301 N H N 302 N H N 303 N H N 304 N N N 305 S C N 306 N C N 307 N O N 308 R C N 309 N O N 310 N C N 311 N O N 312 N H N 313 N H N 314 N H N 315 N H N 316 N H N 317 N H N 318 N H N 319 N H N 320 N H N 321 N N N 322 S C N 323 R C N 324 N C N 325 N O N 326 N P N 327 N O N 328 N O N 329 N O N 330 N C N 331 N O N 332 N O N 333 N H N 334 N H N 335 N H N 336 N H N 337 N H N 338 N H N 339 N H N 340 N H N 341 N H N 342 N H N 343 N N N 344 S C N 345 N C N 346 N O N 347 N C Y 348 N C Y 349 N C Y 350 N C Y 351 N N Y 352 N C Y 353 N C Y 354 N C Y 355 N C Y 356 N C N 357 N O N 358 N H N 359 N H N 360 N H N 361 N H N 362 N H N 363 N H N 364 N H N 365 N H N 366 N H N 367 N H N 368 N H N 369 N H N 370 N N N 371 S C N 372 N C N 373 N O N 374 N C Y 375 N C Y 376 N C Y 377 N C Y 378 N C Y 379 N C Y 380 N C N 381 N O N 382 N O N 383 N H N 384 N H N 385 N H N 386 N H N 387 N H N 388 N H N 389 N H N 390 N H N 391 N H N 392 N H N 393 N H N 394 N N N 395 S C N 396 N C N 397 N O N 398 N C N 399 N C N 400 N C N 401 N O N 402 N H N 403 N H N 404 N H N 405 N H N 406 N H N 407 N H N 408 N H N 409 N H N 410 N H N 411 N H N 412 N H N 1 N sing N 2 N sing N 3 N sing N 4 N sing N 5 N sing N 6 N sing N 7 N doub N 8 N sing N 9 N sing N 10 N sing N 11 N sing N 12 N sing N 13 N sing N 14 N sing N 15 N sing N 16 N sing N 17 N sing N 18 N sing N 19 N doub N 20 N sing N 21 N sing N 22 N sing N 23 N sing N 24 N sing N 25 N sing N 26 N sing N 27 N sing N 28 N sing N 29 N sing N 30 N sing N 31 N sing N 32 N sing N 33 N doub N 34 N sing N 35 N sing N 36 N sing N 37 N sing N 38 N sing N 39 N sing N 40 N sing N 41 N sing N 42 N sing N 43 N sing N 44 N sing N 45 N doub N 46 N sing N 47 N sing N 48 N sing N 49 N sing N 50 N doub N 51 N sing N 52 N sing N 53 N sing N 54 N sing N 55 N sing N 56 N sing N 57 N sing N 58 N sing N 59 N sing N 60 N sing N 61 N doub N 62 N sing N 63 N sing N 64 N sing N 65 N sing N 66 N doub N 67 N sing N 68 N sing N 69 N sing N 70 N sing N 71 N sing N 72 N sing N 73 N sing N 74 N sing N 75 N sing N 76 N doub N 77 N sing N 78 N sing N 79 N sing N 80 N sing N 81 N sing N 82 N sing N 83 N sing N 84 N sing N 85 N sing N 86 N sing N 87 N sing N 88 N sing N 89 N doub N 90 N sing N 91 N sing N 92 N sing N 93 N sing N 94 N sing N 95 N sing N 96 N sing N 97 N doub N 98 N sing N 99 N sing N 100 N sing N 101 N sing N 102 N sing N 103 N sing N 104 N sing N 105 N sing N 106 N sing N 107 N sing N 108 N doub N 109 N sing N 110 N sing N 111 N sing N 112 N sing N 113 N sing N 114 N sing N 115 N sing N 116 N doub N 117 N sing N 118 N sing N 119 N sing N 120 N sing N 121 N sing N 122 N sing N 123 N sing N 124 N sing N 125 N sing N 126 N doub N 127 N sing N 128 N sing N 129 N sing N 130 N sing N 131 N sing N 132 N sing N 133 N sing N 134 N sing N 135 N doub N 136 N sing N 137 N sing N 138 N sing N 139 N sing Y 140 N sing Y 141 N doub Y 142 N doub N 143 N sing Y 144 N sing N 145 N sing Y 146 N sing N 147 N sing N 148 N sing N 149 N sing N 150 N sing N 151 N sing N 152 N sing N 153 N sing N 154 N sing N 155 N sing N 156 N sing N 157 N sing N 158 N doub N 159 N sing N 160 N sing N 161 N sing N 162 N sing N 163 N sing N 164 N sing N 165 N sing N 166 N sing N 167 N sing N 168 N sing N 169 N sing N 170 N sing N 171 N sing N 172 N sing N 173 N sing N 174 N sing N 175 N sing N 176 N sing N 177 N sing N 178 N sing N 179 N doub N 180 N sing N 181 N sing N 182 N sing N 183 N sing N 184 N sing N 185 N sing N 186 N sing N 187 N sing N 188 N sing N 189 N sing N 190 N sing N 191 N sing N 192 N sing N 193 N sing N 194 N sing N 195 N sing N 196 N sing N 197 N sing N 198 N sing N 199 N sing N 200 N doub N 201 N sing N 202 N sing N 203 N sing N 204 N sing N 205 N sing N 206 N sing N 207 N sing N 208 N sing N 209 N sing N 210 N sing N 211 N sing N 212 N sing N 213 N sing N 214 N sing N 215 N sing N 216 N sing N 217 N sing N 218 N sing N 219 N sing N 220 N sing N 221 N sing N 222 N sing N 223 N sing N 224 N doub N 225 N sing N 226 N sing N 227 N sing N 228 N sing N 229 N sing N 230 N sing N 231 N sing N 232 N sing N 233 N sing N 234 N sing N 235 N sing N 236 N sing N 237 N sing N 238 N sing N 239 N sing N 240 N sing N 241 N sing N 242 N sing N 243 N doub N 244 N sing N 245 N sing N 246 N sing N 247 N sing Y 248 N doub Y 249 N sing Y 250 N sing N 251 N sing Y 252 N doub N 253 N sing Y 254 N doub N 255 N sing Y 256 N sing N 257 N sing N 258 N sing N 259 N sing N 260 N sing N 261 N sing N 262 N sing N 263 N sing N 264 N sing N 265 N sing N 266 N doub N 267 N sing N 268 N sing N 269 N sing N 270 N sing N 271 N sing N 272 N sing N 273 N sing N 274 N sing N 275 N sing N 276 N sing N 277 N sing N 278 N sing N 279 N sing N 280 N sing N 281 N sing N 282 N sing N 283 N doub N 284 N sing N 285 N sing N 286 N sing N 287 N sing N 288 N sing N 289 N sing N 290 N sing N 291 N sing N 292 N sing N 293 N sing N 294 N sing N 295 N sing N 296 N doub N 297 N sing N 298 N sing N 299 N sing N 300 N sing N 301 N sing N 302 N sing N 303 N sing N 304 N sing N 305 N sing N 306 N sing N 307 N sing N 308 N sing N 309 N sing N 310 N sing N 311 N sing N 312 N sing N 313 N sing N 314 N sing N 315 N sing N 316 N sing N 317 N sing N 318 N sing N 319 N doub N 320 N sing N 321 N sing N 322 N sing N 323 N sing N 324 N doub N 325 N sing N 326 N sing N 327 N sing N 328 N sing N 329 N sing N 330 N sing N 331 N sing N 332 N sing N 333 N doub N 334 N sing N 335 N sing N 336 N sing N 337 N sing Y 338 N doub Y 339 N sing Y 340 N sing N 341 N sing Y 342 N doub Y 343 N sing Y 344 N sing N 345 N sing Y 346 N sing Y 347 N doub N 348 N sing Y 349 N doub N 350 N sing Y 351 N sing N 352 N sing N 353 N sing N 354 N sing N 355 N sing N 356 N sing N 357 N sing N 358 N sing N 359 N sing N 360 N sing N 361 N doub N 362 N sing N 363 N sing N 364 N sing N 365 N sing Y 366 N doub Y 367 N sing Y 368 N sing N 369 N sing Y 370 N doub N 371 N sing Y 372 N doub N 373 N sing Y 374 N sing N 375 N sing N 376 N sing N 377 N sing N 378 N sing N 379 N sing N 380 N sing N 381 N sing N 382 N sing N 383 N sing N 384 N sing N 385 N doub N 386 N sing N 387 N sing N 388 N sing N 389 N sing N 390 N sing N 391 N sing N 392 N sing N 393 N sing N 394 N sing N 395 N sing N 396 N sing US Cell Cycle 1551-4005 6 1350 1359 10.4161/cc.6.11.4278 17495531 Cyclin B and cyclin A confer different substrate recognition properties on CDK2. 2007 10.2210/pdb2jgz/pdb pdb_00002jgz 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 100.0 1 CCD ADSC CCD SINGLE WAVELENGTH M x-ray 1 0.87260 1.0 ID29 ESRF 0.87260 SYNCHROTRON ESRF BEAMLINE ID29 PHOSPHORYLATED ON THR160 32999.125 CELL DIVISION PROTEIN KINASE 2 2.7.1.- RESIDUES 1-288 1 man polymer 30107.293 G2/MITOTIC-SPECIFIC CYCLIN-B1 RESIDUES 167-426 1 man polymer 18.015 water 5 nat water P33 PROTEIN KINASE CYCLIN B1 no yes SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY (TPO)HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD A polypeptide(L) no no CSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQL VGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYL MELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYAT SKHAKISTLPQLNSALVQDL CSEYVKDIYAYLRQLEEEQAVRPKYLLGREVTGNMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQL VGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFLRRASKIGEVDVEQHTLAKYL MELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEWTPTLQHYLSYTEESLLPVMQHLAKNVVMVNQGLTKHMTVKNKYAT SKHAKISTLPQLNSALVQDL B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n HUMAN sample 9606 HOMO SAPIENS 562 ESCHERICHIA COLI HUMAN sample 9606 HOMO SAPIENS 562 ESCHERICHIA COLI 1 3.11 60.5 6.00 0.9-1.2 M AMMONIUM SULPHATE, 100 MM MES PH 6.0-6.5, 100 MM POTASSIUM CHLORIDE citation pdbx_database_status struct_conn chem_comp_atom chem_comp_bond database_2 pdbx_initial_refinement_model repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations Other Data collection Database references Refinement description 1 0 2007-05-22 1 1 2011-05-08 1 2 2011-07-13 1 3 2019-10-09 1 4 2023-12-13 _citation.journal_id_ISSN _citation.page_last _citation.pdbx_database_id_DOI _citation.title _pdbx_database_status.status_code_sf _struct_conn.pdbx_leaving_atom_flag _database_2.pdbx_DOI _database_2.pdbx_database_accession HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR STAUROSPORINE HUMAN CYCLIN-DEPENDENT KINASE 2 HUMAN CYCLIN-DEPENDENT KINASE 2 PHOSPHORYLATED ON THR 160 CRYSTAL STRUCTURE OF THE HUMAN CDK2 KINASE COMPLEX WITHCELL CYCLE-REGULATORY PROTEIN CKSHS1 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR PURVALANOL B THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH 4-[3- HYDROXYANILINO]-6,7-DIMETHOXYQUINAZOLINE HUMAN CYCLIN-DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR HYMENIALDISINE HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU2058 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU6027 THR 160 PHOSPHORYLATED CDK2 - HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR INDIRUBIN-5- SULPHONATE BOUND CRYSTAL STRUCTURE OF MURINE GAMMA HERPESVIRUS CYCLIN COMPLEXED TO HUMAN CYCLIN DEPENDANT KINASE 2 CYCLIN A - CYCLIN-DEPENDENT KINASE 2 COMPLEX CRYSTAL STRUCTURE OF KINASE ASSOCIATED PHOSPHATASE (KAP) INCOMPLEX WITH PHOSPHO-CDK2 THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) INCOMPLEX WITH AN OXINDOLE INHIBITOR THE STRUCTURE OF CDK2/CYCLIN A IN COMPLEX WITH AN OXINDOLEINHIBITOR CRYSTAL STRUCTURE OF HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2)IN COMPLEX WITH THE INHIBITOR H717 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4INHIBITOR HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4INHIBITOR HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4INHIBITOR PCDK2/CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE SUBSTRATE HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 2-AMINO-6-(3'-METHYL- 2'-OXO)BUTOXYPURINE CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6 -BIS ANILINO PYRIMIDINE CDK4 INHIBITOR CDK2 IN COMPLEX WITH A DISUBSTITUTED 2, 4 -BIS ANILINO PYRIMIDINE CDK4 INHIBITOR CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6 -BIS ANILINO PYRIMIDINE CDK4 INHIBITOR CDK2 IN COMPLEX WITH A DISUBSTITUTED 2, 4 -BIS ANILINO PYRIMIDINE CDK4 INHIBITOR HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 2-AMINO-6-[(R )-PYRROLIDINO-5'-YL]METHOXYPURINE HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 2-AMINO-6-[ CYCLOHEX-3-ENYL]METHOXYPURINE STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE INHIBITOR NU2058 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE INHIBITOR NU6094 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE INHIBITOR NU6086 STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH THE INHIBITOR NU6102 CDK2/CYCLINA IN COMPLEX WITH A 9 RESIDUE RECRUITMENT PEPTIDE FROM E2F CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM E2F CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P53 CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P27 CDK2/CYCLINA IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P107 HUMAN CYCLIN-DEPENDENT KINASE 2 HUMAN CYCLIN-DEPENDENT KINASE 2 PHOSPHORYLATED CYCLIN-DEPENDENT KINASE-2 BOUND TO CYCLIN A P27(KIP1)/CYCLIN A/CDK2 COMPLEX THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) INCOMPLEX WITH 4-[(6-AMINO-4- PYRIMIDINYL)AMINO]BENZENESULFONAMIDE CRYSTAL STRUCTURE OF HUMAN CDK2 ( UNPHOSPHORYLATED) INCOMPLEX WITH PKF049-365 CDK2 COMPLEXED WITH N-METHYL-4-{[(2-OXO- 1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL] AMINO}BENZENESULFONAMIDE CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO -8H-[1,3]THIAZOLO[5,4-E]INDOL-8- YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2- BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3- OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2- ONE CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3 -YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2- YL)BENZENESULFONAMIDE CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[4-({[AMINO(IMINO)METHYL] AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3- DIHYDRO-1H-INDOLE STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 2-ARYLAMINO-4- CYCLOHEXYLMETHYL-5-NITROSO-6-AMINOPYRIMIDINE INHIBITOR STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 6- CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN-DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 6- CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/ CYCLIN A COMPLEXED WITH A 6- CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR CYCLIN A BINDING GROOVE INHIBITOR H-ARG- ARG-LEU-ILE-PHE-NH2 CYCLIN A BINDING GROOVE INHIBITOR AC-ARG- ARG-LEU-ASN-(M-CL-PHE)-NH2 CYCLIN A BINDING GROOVE INHIBITOR H-CIT- CIT-LEU-ILE-(P-F-PHE)-NH2 CYCLIN A BINDING GROOVE INHIBITOR H-ARG- ARG-LEU-ASN-(P-F-PHE)-NH2 THE STRUCTURE OF CYCLIN DEPENDENT KINASE 2 (CKD2) WITH ATRISUBSTITUTED NAPHTHOSTYRIL INHIBITOR THE STRUCURE OF PHOSPHO-CDK2/CYCLIN A IN COMPLEX WITH THEINHIBITOR 4,5,6,7- TETRABROMOBENZOTRIAZOLE (TBS) CRYSTAL STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2COMPLEXED WITH A NUCLEOSIDE INHIBITOR THE CRYSTAL STRUCTURE OF UCN-01 IN COMPLEX WITH PHOSPHO-CDK2/CYCLIN A APO STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 4-(2,5-DICHLORO-THIOPHEN- 3-YL)-PYRIMIDIN-2-YLAMINE HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 4-(2,4-DIMETHYL-THIAZOL- 5-YL)-PYRIMIDIN-2-YLAMINE HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR N-[4-(2,4-DIMETHYL- THIAZOL-5-YL)PYRIMIDIN-2-YL]-N'- HYDROXYIMINOFORMAMIDE HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR [4-(2,4-DIMETHYL-THIAZOL- 5-YL)-PYRIMIDIN-2-YL]-(4-TRIFLUOROMETHYL- PHENYL)-AMINE HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 3-[4-(2,4-DIMETHYL- THIAZOL-5-YL)-PYRIMIDIN-2-YLAMINO]-PHENOL HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR 4-[4-(4-METHYL-2- METHYLAMINO-THIAZOL-5-YL)-PYRIMIDIN-2- YLAMINO]-PHENOL HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR [4-(2-AMINO-4-METHYL- THIAZOL-5-YL)-PYRIMIDIN-2-YL]-(3-NITRO- PHENYL)-AMINE HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THEINHIBITOR N-[4-(2,4-DIMETHYL- THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'- DIMETHYL-BENZENE-1,4-DIAMINE CRYSTAL STRUCTURE OF CDK2 WITH INHIBITOR PHOSPHORYLATED CDK2-CYCLYIN A-SUBSTRATE PEPTIDE COMPLEX CDK2 COMPLEX WITH A 4-ALKYNYL OXINDOLE INHIBITOR CYCLIN A BINDING GROOVE INHIBITOR H-ARG- ARG-LEU-ASN-(P-F-PHE)-NH2 CDK2 IN COMPLEX WITH AN IMIDAZO[1,2-B] PYRIDAZINE CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6 -BIS ANILINO PYRIMIDINE CDK4 INHIBITOR STRUCTURE OF CDK2/CYCLIN A WITH PNU-292137 STRUCTURE OF CDK2 COMPLEXED WITH PNU-181227 CRYSTALS STRUCTURE OF HUMAN CDK2 IN COMPLEX WITH THE INHIBITOR OLOMOUCINE. CO-CRYSTAL STRUCTURE OF 6-CYCLOHEXYLMETHOXY- 8-ISOPROPYL-9H-PURIN-2-YLAMINE AND MONOMERIC CDK2 THE STRUCTURAL BASIS OF CDK2 ACTIVATION BY CYCLIN E SCREENING FOR FRAGMENT BINDING BY X-RAY CRYSTALLOGRAPHY CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A PYRAZOLO[1,5-A]PYRIMIDINE INHIBITOR CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A PYRAZOLO[1,5-A]PYRIMIDINE INHIBITOR CRYSTAL STRUCTURE OF CDK2 WITH AN AMINOIMIDAZO PYRIDINEINHIBITOR HUMAN CDK2 IN COMPLEX WITH OLOMOUCINE II, A NOVEL 2,6,9-TRISUBSTITUTED PURINE CYCLIN -DEPENDENT KINASE INHIBITOR HUMAN CYCLIN-DEPENDENT KINASE 2 IN COMPLEX WITH ROSCOVITINE HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DPH-042562 HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DIN-234325 HUMAN CYCLIN DEPENDENT KINASE 2 (CKD2) COMPLEXED WITH DIN-232305 HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITHINDENOPYRAXOLE DIN-101312 HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 5-BROMO- INDIRUBINE HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THE INHIBITOR 4- HYDROXYPIPERINDINESULFONYL-INDIRUBINE STRUCTURE OF CDK2-CYCLIN A WITH PHA-404611 STRUCTURE OF CDK2-CYCLIN A WITH PHA-630529 STRUCTURE OF CDK2 COMPLEXED WITH PNU-198873 STRUCTURE OF CDK2 COMPLEXED WITH PNU-230032 STRUCTURE OF CDK2-CYCLIN A WITH PHA-533514 DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR THE CRYSTAL STRUCTURE OF CDK2 CYCLIN A IN COMPLEX WITH A SUBSTRATE PEPTIDE DERIVED FROM CDC MODIFIED WITH A GAMMA-LINKED ATP ANALOGUE CRYSTAL STRUCTURE OF PHOSPHO-CDK2 CYCLIN A IN COMPLEX WITH A PEPTIDE CONTAINING BOTH THE SUBSTRATE AND RECRUITMENT SITES OF CDC6 MECHANISM OF CDK INHIBITION BY ACTIVE SITE PHOSPHORYLATION: CDK2 Y15P T160P IN COMPLEX WITH CYCLIN A STRUCTURE 4-ARYLAZO-3,5-DIAMINO-1H-PYRAZOLE CDK INHIBITORS: SAR STUDY, CRYSTAL STRUCTURE IN COMPLEX WITH CDK2, SELECTIVITY, AND CELLULAR EFFECTS HUMAN CDK2 IN COMPLEX WITH ISOPENTENYLADENINE STRUCTURE OF HUMAN THR160-PHOSPHO CDK2- CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR STRUCTURE OF HUMAN THR160-PHOSPHO CDK2- CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR STRUCTURE OF HUMAN THR160-PHOSPHO CDK2- CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR CRYSTAL STRUCTURE OF CDK2 IN COMPLEX WITH MACROCYCLIC AMINOPYRIMIDINE CRYSTAL STRUCTURE OF HUMAN CYCLIN B1 PDBE Y PDBE 2007-02-17 REL REL HOH water RESIDUE SER 0 DERIVES FROM THE EXPRESSION CONSTRUCT A FRAGMENT CONTAINING RESIDUES 165-433 WAS USED IN THIS STUDY 1QMZ PDB ENTRY 1QMZ PDB experimental model HOH 2001 3 HOH HOH 2001 A HOH 2002 3 HOH HOH 2002 A HOH 2003 3 HOH HOH 2003 A HOH 2001 3 HOH HOH 2001 B HOH 2002 3 HOH HOH 2002 B SER 0 n 1 SER 0 A MET 1 n 2 MET 1 A GLU 2 n 3 GLU 2 A ASN 3 n 4 ASN 3 A PHE 4 n 5 PHE 4 A GLN 5 n 6 GLN 5 A LYS 6 n 7 LYS 6 A VAL 7 n 8 VAL 7 A GLU 8 n 9 GLU 8 A LYS 9 n 10 LYS 9 A ILE 10 n 11 ILE 10 A GLY 11 n 12 GLY 11 A GLU 12 n 13 GLU 12 A GLY 13 n 14 GLY 13 A THR 14 n 15 THR 14 A TYR 15 n 16 TYR 15 A GLY 16 n 17 GLY 16 A VAL 17 n 18 VAL 17 A VAL 18 n 19 VAL 18 A TYR 19 n 20 TYR 19 A LYS 20 n 21 LYS 20 A ALA 21 n 22 ALA 21 A ARG 22 n 23 ARG 22 A ASN 23 n 24 ASN 23 A LYS 24 n 25 LYS 24 A LEU 25 n 26 LEU 25 A THR 26 n 27 THR 26 A GLY 27 n 28 GLY 27 A GLU 28 n 29 GLU 28 A VAL 29 n 30 VAL 29 A VAL 30 n 31 VAL 30 A ALA 31 n 32 ALA 31 A LEU 32 n 33 LEU 32 A LYS 33 n 34 LYS 33 A LYS 34 n 35 LYS 34 A ILE 35 n 36 ILE 35 A ARG 36 n 37 ARG 36 A LEU 37 n 38 LEU 37 A ASP 38 n 39 ASP 38 A THR 39 n 40 THR 39 A GLU 40 n 41 GLU 40 A THR 41 n 42 THR 41 A GLU 42 n 43 GLU 42 A GLY 43 n 44 GLY 43 A VAL 44 n 45 VAL 44 A PRO 45 n 46 PRO 45 A SER 46 n 47 SER 46 A THR 47 n 48 THR 47 A ALA 48 n 49 ALA 48 A ILE 49 n 50 ILE 49 A ARG 50 n 51 ARG 50 A GLU 51 n 52 GLU 51 A ILE 52 n 53 ILE 52 A SER 53 n 54 SER 53 A LEU 54 n 55 LEU 54 A LEU 55 n 56 LEU 55 A LYS 56 n 57 LYS 56 A GLU 57 n 58 GLU 57 A LEU 58 n 59 LEU 58 A ASN 59 n 60 ASN 59 A HIS 60 n 61 HIS 60 A PRO 61 n 62 PRO 61 A ASN 62 n 63 ASN 62 A ILE 63 n 64 ILE 63 A VAL 64 n 65 VAL 64 A LYS 65 n 66 LYS 65 A LEU 66 n 67 LEU 66 A LEU 67 n 68 LEU 67 A ASP 68 n 69 ASP 68 A VAL 69 n 70 VAL 69 A ILE 70 n 71 ILE 70 A HIS 71 n 72 HIS 71 A THR 72 n 73 THR 72 A GLU 73 n 74 GLU 73 A ASN 74 n 75 ASN 74 A LYS 75 n 76 LYS 75 A LEU 76 n 77 LEU 76 A TYR 77 n 78 TYR 77 A LEU 78 n 79 LEU 78 A VAL 79 n 80 VAL 79 A PHE 80 n 81 PHE 80 A GLU 81 n 82 GLU 81 A PHE 82 n 83 PHE 82 A LEU 83 n 84 LEU 83 A HIS 84 n 85 HIS 84 A GLN 85 n 86 GLN 85 A ASP 86 n 87 ASP 86 A LEU 87 n 88 LEU 87 A LYS 88 n 89 LYS 88 A LYS 89 n 90 LYS 89 A PHE 90 n 91 PHE 90 A MET 91 n 92 MET 91 A ASP 92 n 93 ASP 92 A ALA 93 n 94 ALA 93 A SER 94 n 95 SER 94 A ALA 95 n 96 ALA 95 A LEU 96 n 97 LEU 96 A THR 97 n 98 THR 97 A GLY 98 n 99 GLY 98 A ILE 99 n 100 ILE 99 A PRO 100 n 101 PRO 100 A LEU 101 n 102 LEU 101 A PRO 102 n 103 PRO 102 A LEU 103 n 104 LEU 103 A ILE 104 n 105 ILE 104 A LYS 105 n 106 LYS 105 A SER 106 n 107 SER 106 A TYR 107 n 108 TYR 107 A LEU 108 n 109 LEU 108 A PHE 109 n 110 PHE 109 A GLN 110 n 111 GLN 110 A LEU 111 n 112 LEU 111 A LEU 112 n 113 LEU 112 A GLN 113 n 114 GLN 113 A GLY 114 n 115 GLY 114 A LEU 115 n 116 LEU 115 A ALA 116 n 117 ALA 116 A PHE 117 n 118 PHE 117 A CYS 118 n 119 CYS 118 A HIS 119 n 120 HIS 119 A SER 120 n 121 SER 120 A HIS 121 n 122 HIS 121 A ARG 122 n 123 ARG 122 A VAL 123 n 124 VAL 123 A LEU 124 n 125 LEU 124 A HIS 125 n 126 HIS 125 A ARG 126 n 127 ARG 126 A ASP 127 n 128 ASP 127 A LEU 128 n 129 LEU 128 A LYS 129 n 130 LYS 129 A PRO 130 n 131 PRO 130 A GLN 131 n 132 GLN 131 A ASN 132 n 133 ASN 132 A LEU 133 n 134 LEU 133 A LEU 134 n 135 LEU 134 A ILE 135 n 136 ILE 135 A ASN 136 n 137 ASN 136 A THR 137 n 138 THR 137 A GLU 138 n 139 GLU 138 A GLY 139 n 140 GLY 139 A ALA 140 n 141 ALA 140 A ILE 141 n 142 ILE 141 A LYS 142 n 143 LYS 142 A LEU 143 n 144 LEU 143 A ALA 144 n 145 ALA 144 A ASP 145 n 146 ASP 145 A PHE 146 n 147 PHE 146 A GLY 147 n 148 GLY 147 A LEU 148 n 149 LEU 148 A ALA 149 n 150 ALA 149 A ARG 150 n 151 ARG 150 A ALA 151 n 152 ALA 151 A PHE 152 n 153 PHE 152 A GLY 153 n 154 GLY 153 A VAL 154 n 155 VAL 154 A PRO 155 n 156 PRO 155 A VAL 156 n 157 VAL 156 A ARG 157 n 158 ARG 157 A THR 158 n 159 THR 158 A TYR 159 n 160 TYR 159 A TPO 160 n 161 TPO 160 A HIS 161 n 162 HIS 161 A GLU 162 n 163 GLU 162 A VAL 163 n 164 VAL 163 A VAL 164 n 165 VAL 164 A THR 165 n 166 THR 165 A LEU 166 n 167 LEU 166 A TRP 167 n 168 TRP 167 A TYR 168 n 169 TYR 168 A ARG 169 n 170 ARG 169 A ALA 170 n 171 ALA 170 A PRO 171 n 172 PRO 171 A GLU 172 n 173 GLU 172 A ILE 173 n 174 ILE 173 A LEU 174 n 175 LEU 174 A LEU 175 n 176 LEU 175 A GLY 176 n 177 GLY 176 A CYS 177 n 178 CYS 177 A LYS 178 n 179 LYS 178 A TYR 179 n 180 TYR 179 A TYR 180 n 181 TYR 180 A SER 181 n 182 SER 181 A THR 182 n 183 THR 182 A ALA 183 n 184 ALA 183 A VAL 184 n 185 VAL 184 A ASP 185 n 186 ASP 185 A ILE 186 n 187 ILE 186 A TRP 187 n 188 TRP 187 A SER 188 n 189 SER 188 A LEU 189 n 190 LEU 189 A GLY 190 n 191 GLY 190 A CYS 191 n 192 CYS 191 A ILE 192 n 193 ILE 192 A PHE 193 n 194 PHE 193 A ALA 194 n 195 ALA 194 A GLU 195 n 196 GLU 195 A MET 196 n 197 MET 196 A VAL 197 n 198 VAL 197 A THR 198 n 199 THR 198 A ARG 199 n 200 ARG 199 A ARG 200 n 201 ARG 200 A ALA 201 n 202 ALA 201 A LEU 202 n 203 LEU 202 A PHE 203 n 204 PHE 203 A PRO 204 n 205 PRO 204 A GLY 205 n 206 GLY 205 A ASP 206 n 207 ASP 206 A SER 207 n 208 SER 207 A GLU 208 n 209 GLU 208 A ILE 209 n 210 ILE 209 A ASP 210 n 211 ASP 210 A GLN 211 n 212 GLN 211 A LEU 212 n 213 LEU 212 A PHE 213 n 214 PHE 213 A ARG 214 n 215 ARG 214 A ILE 215 n 216 ILE 215 A PHE 216 n 217 PHE 216 A ARG 217 n 218 ARG 217 A THR 218 n 219 THR 218 A LEU 219 n 220 LEU 219 A GLY 220 n 221 GLY 220 A THR 221 n 222 THR 221 A PRO 222 n 223 PRO 222 A ASP 223 n 224 ASP 223 A GLU 224 n 225 GLU 224 A VAL 225 n 226 VAL 225 A VAL 226 n 227 VAL 226 A TRP 227 n 228 TRP 227 A PRO 228 n 229 PRO 228 A GLY 229 n 230 GLY 229 A VAL 230 n 231 VAL 230 A THR 231 n 232 THR 231 A SER 232 n 233 SER 232 A MET 233 n 234 MET 233 A PRO 234 n 235 PRO 234 A ASP 235 n 236 ASP 235 A TYR 236 n 237 TYR 236 A LYS 237 n 238 LYS 237 A PRO 238 n 239 PRO 238 A SER 239 n 240 SER 239 A PHE 240 n 241 PHE 240 A PRO 241 n 242 PRO 241 A LYS 242 n 243 LYS 242 A TRP 243 n 244 TRP 243 A ALA 244 n 245 ALA 244 A ARG 245 n 246 ARG 245 A GLN 246 n 247 GLN 246 A ASP 247 n 248 ASP 247 A PHE 248 n 249 PHE 248 A SER 249 n 250 SER 249 A LYS 250 n 251 LYS 250 A VAL 251 n 252 VAL 251 A VAL 252 n 253 VAL 252 A PRO 253 n 254 PRO 253 A PRO 254 n 255 PRO 254 A LEU 255 n 256 LEU 255 A ASP 256 n 257 ASP 256 A GLU 257 n 258 GLU 257 A ASP 258 n 259 ASP 258 A GLY 259 n 260 GLY 259 A ARG 260 n 261 ARG 260 A SER 261 n 262 SER 261 A LEU 262 n 263 LEU 262 A LEU 263 n 264 LEU 263 A SER 264 n 265 SER 264 A GLN 265 n 266 GLN 265 A MET 266 n 267 MET 266 A LEU 267 n 268 LEU 267 A HIS 268 n 269 HIS 268 A TYR 269 n 270 TYR 269 A ASP 270 n 271 ASP 270 A PRO 271 n 272 PRO 271 A ASN 272 n 273 ASN 272 A LYS 273 n 274 LYS 273 A ARG 274 n 275 ARG 274 A ILE 275 n 276 ILE 275 A SER 276 n 277 SER 276 A ALA 277 n 278 ALA 277 A LYS 278 n 279 LYS 278 A ALA 279 n 280 ALA 279 A ALA 280 n 281 ALA 280 A LEU 281 n 282 LEU 281 A ALA 282 n 283 ALA 282 A HIS 283 n 284 HIS 283 A PRO 284 n 285 PRO 284 A PHE 285 n 286 PHE 285 A PHE 286 n 287 PHE 286 A GLN 287 n 288 GLN 287 A ASP 288 n 289 ASP 288 A CYS 167 n 1 CYS 167 B SER 168 n 2 SER 168 B GLU 169 n 3 GLU 169 B TYR 170 n 4 TYR 170 B VAL 171 n 5 VAL 171 B LYS 172 n 6 LYS 172 B ASP 173 n 7 ASP 173 B ILE 174 n 8 ILE 174 B TYR 175 n 9 TYR 175 B ALA 176 n 10 ALA 176 B TYR 177 n 11 TYR 177 B LEU 178 n 12 LEU 178 B ARG 179 n 13 ARG 179 B GLN 180 n 14 GLN 180 B LEU 181 n 15 LEU 181 B GLU 182 n 16 GLU 182 B GLU 183 n 17 GLU 183 B GLU 184 n 18 GLU 184 B GLN 185 n 19 GLN 185 B ALA 186 n 20 ALA 186 B VAL 187 n 21 VAL 187 B ARG 188 n 22 ARG 188 B PRO 189 n 23 PRO 189 B LYS 190 n 24 LYS 190 B TYR 191 n 25 TYR 191 B LEU 192 n 26 LEU 192 B LEU 193 n 27 LEU 193 B GLY 194 n 28 GLY 194 B ARG 195 n 29 ARG 195 B GLU 196 n 30 GLU 196 B VAL 197 n 31 VAL 197 B THR 198 n 32 THR 198 B GLY 199 n 33 GLY 199 B ASN 200 n 34 ASN 200 B MET 201 n 35 MET 201 B ARG 202 n 36 ARG 202 B ALA 203 n 37 ALA 203 B ILE 204 n 38 ILE 204 B LEU 205 n 39 LEU 205 B ILE 206 n 40 ILE 206 B ASP 207 n 41 ASP 207 B TRP 208 n 42 TRP 208 B LEU 209 n 43 LEU 209 B VAL 210 n 44 VAL 210 B GLN 211 n 45 GLN 211 B VAL 212 n 46 VAL 212 B GLN 213 n 47 GLN 213 B MET 214 n 48 MET 214 B LYS 215 n 49 LYS 215 B PHE 216 n 50 PHE 216 B ARG 217 n 51 ARG 217 B LEU 218 n 52 LEU 218 B LEU 219 n 53 LEU 219 B GLN 220 n 54 GLN 220 B GLU 221 n 55 GLU 221 B THR 222 n 56 THR 222 B MET 223 n 57 MET 223 B TYR 224 n 58 TYR 224 B MET 225 n 59 MET 225 B THR 226 n 60 THR 226 B VAL 227 n 61 VAL 227 B SER 228 n 62 SER 228 B ILE 229 n 63 ILE 229 B ILE 230 n 64 ILE 230 B ASP 231 n 65 ASP 231 B ARG 232 n 66 ARG 232 B PHE 233 n 67 PHE 233 B MET 234 n 68 MET 234 B GLN 235 n 69 GLN 235 B ASN 236 n 70 ASN 236 B ASN 237 n 71 ASN 237 B CYS 238 n 72 CYS 238 B VAL 239 n 73 VAL 239 B PRO 240 n 74 PRO 240 B LYS 241 n 75 LYS 241 B LYS 242 n 76 LYS 242 B MET 243 n 77 MET 243 B LEU 244 n 78 LEU 244 B GLN 245 n 79 GLN 245 B LEU 246 n 80 LEU 246 B VAL 247 n 81 VAL 247 B GLY 248 n 82 GLY 248 B VAL 249 n 83 VAL 249 B THR 250 n 84 THR 250 B ALA 251 n 85 ALA 251 B MET 252 n 86 MET 252 B PHE 253 n 87 PHE 253 B ILE 254 n 88 ILE 254 B ALA 255 n 89 ALA 255 B SER 256 n 90 SER 256 B LYS 257 n 91 LYS 257 B TYR 258 n 92 TYR 258 B GLU 259 n 93 GLU 259 B GLU 260 n 94 GLU 260 B MET 261 n 95 MET 261 B TYR 262 n 96 TYR 262 B PRO 263 n 97 PRO 263 B PRO 264 n 98 PRO 264 B GLU 265 n 99 GLU 265 B ILE 266 n 100 ILE 266 B GLY 267 n 101 GLY 267 B ASP 268 n 102 ASP 268 B PHE 269 n 103 PHE 269 B ALA 270 n 104 ALA 270 B PHE 271 n 105 PHE 271 B VAL 272 n 106 VAL 272 B THR 273 n 107 THR 273 B ASP 274 n 108 ASP 274 B ASN 275 n 109 ASN 275 B THR 276 n 110 THR 276 B TYR 277 n 111 TYR 277 B THR 278 n 112 THR 278 B LYS 279 n 113 LYS 279 B HIS 280 n 114 HIS 280 B GLN 281 n 115 GLN 281 B ILE 282 n 116 ILE 282 B ARG 283 n 117 ARG 283 B GLN 284 n 118 GLN 284 B MET 285 n 119 MET 285 B GLU 286 n 120 GLU 286 B MET 287 n 121 MET 287 B LYS 288 n 122 LYS 288 B ILE 289 n 123 ILE 289 B LEU 290 n 124 LEU 290 B ARG 291 n 125 ARG 291 B ALA 292 n 126 ALA 292 B LEU 293 n 127 LEU 293 B ASN 294 n 128 ASN 294 B PHE 295 n 129 PHE 295 B GLY 296 n 130 GLY 296 B LEU 297 n 131 LEU 297 B GLY 298 n 132 GLY 298 B ARG 299 n 133 ARG 299 B PRO 300 n 134 PRO 300 B LEU 301 n 135 LEU 301 B PRO 302 n 136 PRO 302 B LEU 303 n 137 LEU 303 B HIS 304 n 138 HIS 304 B PHE 305 n 139 PHE 305 B LEU 306 n 140 LEU 306 B ARG 307 n 141 ARG 307 B ARG 308 n 142 ARG 308 B ALA 309 n 143 ALA 309 B SER 310 n 144 SER 310 B LYS 311 n 145 LYS 311 B ILE 312 n 146 ILE 312 B GLY 313 n 147 GLY 313 B GLU 314 n 148 GLU 314 B VAL 315 n 149 VAL 315 B ASP 316 n 150 ASP 316 B VAL 317 n 151 VAL 317 B GLU 318 n 152 GLU 318 B GLN 319 n 153 GLN 319 B HIS 320 n 154 HIS 320 B THR 321 n 155 THR 321 B LEU 322 n 156 LEU 322 B ALA 323 n 157 ALA 323 B LYS 324 n 158 LYS 324 B TYR 325 n 159 TYR 325 B LEU 326 n 160 LEU 326 B MET 327 n 161 MET 327 B GLU 328 n 162 GLU 328 B LEU 329 n 163 LEU 329 B THR 330 n 164 THR 330 B MET 331 n 165 MET 331 B LEU 332 n 166 LEU 332 B ASP 333 n 167 ASP 333 B TYR 334 n 168 TYR 334 B ASP 335 n 169 ASP 335 B MET 336 n 170 MET 336 B VAL 337 n 171 VAL 337 B HIS 338 n 172 HIS 338 B PHE 339 n 173 PHE 339 B PRO 340 n 174 PRO 340 B PRO 341 n 175 PRO 341 B SER 342 n 176 SER 342 B GLN 343 n 177 GLN 343 B ILE 344 n 178 ILE 344 B ALA 345 n 179 ALA 345 B ALA 346 n 180 ALA 346 B GLY 347 n 181 GLY 347 B ALA 348 n 182 ALA 348 B PHE 349 n 183 PHE 349 B CYS 350 n 184 CYS 350 B LEU 351 n 185 LEU 351 B ALA 352 n 186 ALA 352 B LEU 353 n 187 LEU 353 B LYS 354 n 188 LYS 354 B ILE 355 n 189 ILE 355 B LEU 356 n 190 LEU 356 B ASP 357 n 191 ASP 357 B ASN 358 n 192 ASN 358 B GLY 359 n 193 GLY 359 B GLU 360 n 194 GLU 360 B TRP 361 n 195 TRP 361 B THR 362 n 196 THR 362 B PRO 363 n 197 PRO 363 B THR 364 n 198 THR 364 B LEU 365 n 199 LEU 365 B GLN 366 n 200 GLN 366 B HIS 367 n 201 HIS 367 B TYR 368 n 202 TYR 368 B LEU 369 n 203 LEU 369 B SER 370 n 204 SER 370 B TYR 371 n 205 TYR 371 B THR 372 n 206 THR 372 B GLU 373 n 207 GLU 373 B GLU 374 n 208 GLU 374 B SER 375 n 209 SER 375 B LEU 376 n 210 LEU 376 B LEU 377 n 211 LEU 377 B PRO 378 n 212 PRO 378 B VAL 379 n 213 VAL 379 B MET 380 n 214 MET 380 B GLN 381 n 215 GLN 381 B HIS 382 n 216 HIS 382 B LEU 383 n 217 LEU 383 B ALA 384 n 218 ALA 384 B LYS 385 n 219 LYS 385 B ASN 386 n 220 ASN 386 B VAL 387 n 221 VAL 387 B VAL 388 n 222 VAL 388 B MET 389 n 223 MET 389 B VAL 390 n 224 VAL 390 B ASN 391 n 225 ASN 391 B GLN 392 n 226 GLN 392 B GLY 393 n 227 GLY 393 B LEU 394 n 228 LEU 394 B THR 395 n 229 THR 395 B LYS 396 n 230 LYS 396 B HIS 397 n 231 HIS 397 B MET 398 n 232 MET 398 B THR 399 n 233 THR 399 B VAL 400 n 234 VAL 400 B LYS 401 n 235 LYS 401 B ASN 402 n 236 ASN 402 B LYS 403 n 237 LYS 403 B TYR 404 n 238 TYR 404 B ALA 405 n 239 ALA 405 B THR 406 n 240 THR 406 B SER 407 n 241 SER 407 B LYS 408 n 242 LYS 408 B HIS 409 n 243 HIS 409 B ALA 410 n 244 ALA 410 B LYS 411 n 245 LYS 411 B ILE 412 n 246 ILE 412 B SER 413 n 247 SER 413 B THR 414 n 248 THR 414 B LEU 415 n 249 LEU 415 B PRO 416 n 250 PRO 416 B GLN 417 n 251 GLN 417 B LEU 418 n 252 LEU 418 B ASN 419 n 253 ASN 419 B SER 420 n 254 SER 420 B ALA 421 n 255 ALA 421 B LEU 422 n 256 LEU 422 B VAL 423 n 257 VAL 423 B GLN 424 n 258 GLN 424 B ASP 425 n 259 ASP 425 B LEU 426 n 260 LEU 426 B author_and_software_defined_assembly PQS 2 dimeric A TPO 160 PHOSPHOTHREONINE A TPO 161 THR 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N ILE 10 A N ILE 11 A O VAL 18 A O VAL 19 A N ALA 21 A N ALA 22 A O VAL 30 A O VAL 31 A N ILE 35 A N ILE 36 A O LEU 76 A O LEU 77 A O VAL 79 A O VAL 80 A N LEU 67 A N LEU 68 A N GLN 85 A N GLN 86 A O ILE 135 A O ILE 136 A N LEU 134 A N LEU 135 A O LYS 142 A O LYS 143 A N LEU 124 A N LEU 125 A O ARG 150 A O ARG 151 1 A A OE1 NH2 GLU ARG 57 122 2.02 1 A A THR GLU 72 73 -149.52 1 A ASN 59 -160.82 97.97 1 A GLU 73 -20.71 38.49 1 A ASN 74 -156.14 -14.88 1 A SER 94 -83.82 36.06 1 A ASP 127 -163.75 45.03 1 A ASP 145 51.61 74.66 1 A VAL 164 66.31 139.22 1 A SER 181 -145.65 -153.45 1 A ARG 199 78.21 -17.84 1 A TRP 227 -150.39 75.84 1 A SER 239 -63.93 25.07 1 A ASP 256 -58.54 174.96 1 A PHE 286 -91.85 39.88 1 A GLN 287 -22.90 -88.04 1 B GLN 185 -106.06 46.45 1 B ARG 299 -38.88 123.33 1 B ILE 312 -116.62 79.51 1 B ASP 335 -59.52 -3.23 1 B LEU 356 -103.82 -155.58 1 B ASP 357 -28.89 -81.49 1 B ASN 358 -150.74 -20.32 1 B TRP 361 -66.59 84.73 1 B LYS 411 40.11 28.49 1 B LEU 415 -34.13 141.84 1 B PRO 416 -63.09 76.25 1 B LEU 418 -108.20 66.59 1 B LEU 422 -81.74 49.36 1 B VAL 423 -109.81 70.80 36.82 0.02000 0.01000 0.00000 0.02000 0.00000 -0.03000 0.923 0.864 HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. 0.275 0.205 0.208 2.90 29.64 979 17963 5.200 99.9 15.137 0.294 RANDOM 1 THROUGHOUT MOLECULAR REPLACEMENT 2.771 0.403 0.80 0.80 1.40 PDB ENTRY 1QMZ MAXIMUM LIKELIHOOD MASK 2.90 29.64 5 4437 0 0 4432 0.012 0.022 4535 1.442 1.974 6144 6.742 5.000 547 38.234 23.819 199 19.630 15.000 820 20.071 15.000 26 0.098 0.200 694 0.004 0.020 3359 0.231 0.200 2085 0.316 0.200 3151 0.171 0.200 127 0.246 0.200 35 0.180 0.200 3 0.682 1.500 2807 1.228 2.000 4457 1.514 3.000 1938 2.535 4.500 1687 0.3410 0.2720 2.98 74 1267 20 2.900 30.180 2JGZ 19123 2.000 0.12000 1 16.7000 8.800 99.9 0.52000 2.90 3.06 3.500 1 8.20 100.0 refinement REFMAC 5.2.0019 data reduction MOSFLM data scaling SCALA phasing PHASER Crystal structure of phospho-CDK2 in complex with Cyclin B 1 N N 2 N N 3 N N 3 N N A PRO 45 A PRO 46 HELX_P A LEU 58 A LEU 59 1 1 14 A LEU 87 A LEU 88 HELX_P A SER 94 A SER 95 1 2 8 A PRO 100 A PRO 101 HELX_P A SER 120 A SER 121 1 3 21 A LYS 129 A LYS 130 HELX_P A GLN 131 A GLN 132 5 4 3 A THR 165 A THR 166 HELX_P A ARG 169 A ARG 170 5 5 5 A ALA 170 A ALA 171 HELX_P A LEU 175 A LEU 176 1 6 6 A THR 182 A THR 183 HELX_P A ARG 199 A ARG 200 1 7 18 A SER 207 A SER 208 HELX_P A GLY 220 A GLY 221 1 8 14 A GLY 229 A GLY 230 HELX_P A MET 233 A MET 234 5 9 5 A ASP 247 A ASP 248 HELX_P A VAL 252 A VAL 253 1 10 6 A ASP 256 A ASP 257 HELX_P A MET 266 A MET 267 1 11 11 A SER 276 A SER 277 HELX_P A LEU 281 A LEU 282 1 12 6 A ALA 282 A ALA 283 HELX_P A GLN 287 A GLN 288 5 13 6 B TYR 170 B TYR 4 HELX_P B GLN 185 B GLN 19 1 14 16 B THR 198 B THR 32 HELX_P B ARG 217 B ARG 51 1 15 20 B LEU 219 B LEU 53 HELX_P B GLN 235 B GLN 69 1 16 17 B PRO 240 B PRO 74 HELX_P B LYS 242 B LYS 76 5 17 3 B MET 243 B MET 77 HELX_P B GLU 260 B GLU 94 1 18 18 B GLU 265 B GLU 99 HELX_P B THR 273 B THR 107 1 19 9 B THR 278 B THR 112 HELX_P B ASN 294 B ASN 128 1 20 17 B LEU 301 B LEU 135 HELX_P B ILE 312 B ILE 146 1 21 12 B ASP 316 B ASP 150 HELX_P B MET 331 B MET 165 1 22 16 B LEU 332 B LEU 166 HELX_P B VAL 337 B VAL 171 5 23 6 B PRO 340 B PRO 174 HELX_P B LEU 356 B LEU 190 1 24 17 B THR 362 B THR 196 HELX_P B LEU 369 B LEU 203 1 25 8 B THR 372 B THR 206 HELX_P B GLN 392 B GLN 226 1 26 21 B MET 398 B MET 232 HELX_P B TYR 404 B TYR 238 1 27 7 B THR 406 B THR 240 HELX_P B ALA 410 B ALA 244 5 28 5 B LYS 411 B LYS 245 HELX_P B LEU 415 B LEU 249 5 29 5 covale 1.320 both A TYR 159 A C TYR 160 1_555 A TPO 160 A N TPO 161 1_555 covale 1.331 both A TPO 160 A C TPO 161 1_555 A HIS 161 A N HIS 162 1_555 TRANSFERASE PROTEIN KINASE, UBL CONJUGATION, PHOSPHORYLATION, SERINE/THREONINE-PROTEIN KINASE, KINASE, CYCLIN, MITOSIS, CELL CYCLE, TRANSFERASE, ATP-BINDING, POLYMORPHISM, CELL DIVISION, NUCLEOTIDE-BINDING, SUBSTRATE SPECIFICITY A VAL 154 A VAL 155 1 A PRO 155 A PRO 156 7.59 B ILE 312 B ILE 146 1 B GLY 313 B GLY 147 -3.48 B GLY 313 B GLY 147 1 B GLU 314 B GLU 148 -3.26 B ASP 357 B ASP 191 1 B ASN 358 B ASN 192 -14.05 B ASP 425 B ASP 259 1 B LEU 426 B LEU 260 -12.31 2JGZ PDB 1 2JGZ CDK2_HUMAN UNP 1 P24941 CCNB1_HUMAN UNP 2 P14635 0 0 2JGZ 0 0 2JGZ A 1 1 1 1 288 2JGZ 1 288 P24941 A 2 2 289 167 426 2JGZ 167 426 P14635 B 3 1 260 5 3 2 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A PHE 4 A PHE 5 A GLU 12 A GLU 13 A VAL 17 A VAL 18 A ASN 23 A ASN 24 A VAL 29 A VAL 30 A ARG 36 A ARG 37 A LYS 75 A LYS 76 A GLU 81 A GLU 82 A LEU 66 A LEU 67 A THR 72 A THR 73 A GLN 85 A GLN 86 A ASP 86 A ASP 87 A LEU 133 A LEU 134 A ILE 135 A ILE 136 A ILE 141 A ILE 142 A LEU 143 A LEU 144 A VAL 123 A VAL 124 A LEU 124 A LEU 125 A ARG 150 A ARG 151 A ALA 151 A ALA 152 178 P 61 2 2